# RevHealth

> RevHealth is a Morristown, New Jersey-based independent healthcare communications agency that helps pharmaceutical, biotech and medical-device companies translate science into medical education, market-access strategy, brand launches, patient advocacy and omnichannel campaigns. Its recent reset is built around joining those disciplines earlier and using AI to compress repetitive agency work while leaving medical accuracy, regulatory judgment and creative decisions with people.

- **Founded:** 2006
- **Headquarters:** Morristown, United States
- **Founders:** Bruce Epstein (Co-founder and former managing partner), Bruce Medd (Co-founder and former managing partner), Brian Wheeler (Co-founder and former managing partner)
- **Products:** Brand marketing, Medical communications, Access, Corporate communications, AI-enabled agency operations
- **Notable:** Grew from about $12 million to more than $16 million in revenue in 2012, according to an MM+M Agency 100 profile., Reached $52 million in revenue in 2022 before an 8% decline to $48 million in 2023., Reported AI adoption by more than 90% of staff, with over half using it daily.

## Products & services

- **Brand marketing** — Brand strategy, positioning, experience design, launch activation and growth programs for healthcare products.
- **Medical communications** — Medical-affairs strategy, medical education, peer-to-peer programs and compliant scientific content.
- **Access** — Value narratives, payer engagement, trade communications, pull-through and patient-support strategy designed to remove coverage barriers.
- **Corporate communications** — Public relations, reputation, issues management, stakeholder influence and patient advocacy.
- **AI-enabled agency operations** — AI-supported briefing, planning, content drafting, claims libraries, prototyping, analytics and scoping. Introduced publicly as AgencyOS in 2024; current messaging emphasizes flexible tools embedded in everyday work.

## Achievements

- Grew from about $12 million to more than $16 million in revenue in 2012, according to an MM+M Agency 100 profile.
- Reached $52 million in revenue in 2022 before an 8% decline to $48 million in 2023.
- Reported AI adoption by more than 90% of staff, with over half using it daily.
- Reported a 50% reduction in project kickoff time and more than 40% compression in editorial and QA workflows.
- Delivered a rare-disease medical broadcast three days after FDA approval despite late label changes.
- Reported payer-campaign click-through rates 422% above control baselines in an oncology access engagement.
- United seven national organizations through a shared chronic GVHD advocacy platform.
- Won Best Professional Experiential Campaign at the 2026 Med Ad News Awards for Daiichi Sankyo's Purpose Takes Root campaign.

## Latest updates

- **2026-06** — CEO Ben Beckley discussed integrated biopharma strategy across medical, access and marketing in a Fierce Biotech interview.
- **2026-04** — Beckley outlined a strategy for structuring credible, machine-readable evidence for AI-mediated pharma discovery in PharmaShots.
- **2026-09** — RevHealth's Purpose Takes Root work for Daiichi Sankyo won Best Professional Experiential Campaign at the Med Ad News Awards.
- **2025-05** — The agency published its view on data differentiation and oncology education ahead of ASCO 2025.
- **2024-09** — William Martino and Julia Sanders joined the executive team in newly created commercial and client leadership roles.
- **2024-07** — RevHealth introduced AgencyOS with PixieDust Labs, claiming a banner-development workflow fell from two weeks to seven minutes.

## Links

- Website: https://www.revhealth.com/
- LinkedIn: https://www.linkedin.com/company/revhealth
- Twitter/X: https://twitter.com/RevHealthLLC
- Facebook: https://www.facebook.com/revhealthllc/

---

Profile page: https://yespress.io/revhealth
Published by YesPress — https://yespress.io
Last updated: 2026-09-23